Pulmatrix, Inc. (PULM)
1.31
-0.01
(-0.76%)
USD |
NASDAQ |
Apr 02, 16:00
1.29
-0.02
(-1.53%)
After-Hours: 20:00
Pulmatrix EPS Diluted (Quarterly) : -0.2541 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Kodiak Sciences, Inc. | -1.042 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.928M |
| Total Expenses (Quarterly) | 0.928M |
| Enterprise Value | 0.6965M |
| Earnings Yield | -107.9% |
| Normalized Earnings Yield | -108.87 |